DJIA 16,204.97 -211.61 -1.29%
NASDAQ 4,363.14 -146.42 -3.25%
S&P 500 1,880.05 -35.40 -1.85%
market minute promo

35.99 -1.08 (-2.91%)

REAL-TIME: Last trade at

Extended Hours: $35.99 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

NBIX $35.99 -2.91%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $36.70
Previous Close $37.07
Daily Range $34.90 - $37.10
52-Week Range $32.67 - $58.46
Market Cap $3.1B
P/E Ratio -38.61
Dividend (Yield) $0.00 (0.0%)
Volume 2,333,320
Average Daily Volume 1,347,134
Current FY EPS -$1.01

Sector

Healthcare

Industry

Drug Makers

Neurocrine Biosciences, Inc. (NBIX) Description

Discovers, develops and intend to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Product candidates will target insomnia, anxiety, depression, cancer, diabetes, and multiple sclerosis. Website: http://www.neurocrine.com/

News & Commentary Rss Feed

Why Neurocrine Biosciences Inc.'s Stock Skyrocketed 147% Higher in 2015

Clinical progress on its late-stage pipeline has investors feeling bullish.

Sum Up The Pieces: PDP Could Be Worth $45

Noteworthy ETF Outflows: IWO, CASY, MTN, NBIX

Neurocrine Biosciences (NBIX) Shares Cross Below 200 DMA

Top Biotech Stock Favorites to Buy With Up to 100% Upside Potential

Neurocrine Announces Successful Completion of Phase Ib T-Force Study of VMAT2 Inhibitor NBI-98854 in

Neurocrine Announces Successful Completion of Phase Ib T-Force Study of VMAT2 Inhibitor NBI-98854 in Adolescents and Children with Tourette Syndrome

Icahn School Of Medicine At Mount Sanai Files Complaint Against Neurocrine Sciences For Breach Of Co

Icahn School Of Medicine At Mount Sanai Files Complaint Against Neurocrine Sciences For Breach Of Contract - 8-K Filings

IWO, TYL, MANH, NBIX: Large Inflows Detected at ETF

JPMorgan Likes These 5 Biotech Stocks

Neurocrine Biosciences Has The Flash And The Cash

See More NBIX News...

NBIX's Top Competitors

NBIX $35.99 (-2.91%)
Current stock: NBIX
AMGN $145.04 (-3.25%)
Current stock: AMGN
GILD $85.14 (-1.78%)
Current stock: GILD
BIIB $263.86 (-3.44%)
Current stock: BIIB